51,400 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Acquired by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,400 shares of the company’s stock, valued at approximately $1,184,000.

Other institutional investors also recently modified their holdings of the company. Covestor Ltd increased its holdings in shares of Privia Health Group by 8.3% in the third quarter. Covestor Ltd now owns 6,703 shares of the company’s stock valued at $154,000 after buying an additional 514 shares in the last quarter. International Assets Investment Management LLC increased its holdings in shares of Privia Health Group by 2,721.7% in the fourth quarter. International Assets Investment Management LLC now owns 7,139 shares of the company’s stock valued at $164,000 after buying an additional 6,886 shares in the last quarter. Assetmark Inc. increased its holdings in shares of Privia Health Group by 17.6% in the third quarter. Assetmark Inc. now owns 7,384 shares of the company’s stock valued at $170,000 after buying an additional 1,107 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Privia Health Group by 30.7% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 8,214 shares of the company’s stock valued at $189,000 after buying an additional 1,928 shares in the last quarter. Finally, Everence Capital Management Inc. bought a new position in shares of Privia Health Group in the third quarter valued at $214,000. Institutional investors own 94.48% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on PRVA. Canaccord Genuity Group dropped their price target on Privia Health Group from $41.00 to $37.00 and set a “buy” rating on the stock in a report on Tuesday, March 19th. Barclays began coverage on shares of Privia Health Group in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $22.00 price objective on the stock. Truist Financial lowered their price objective on shares of Privia Health Group from $32.00 to $28.00 and set a “buy” rating on the stock in a research report on Thursday, February 29th. TD Cowen lowered their price objective on shares of Privia Health Group from $30.00 to $26.00 and set an “outperform” rating on the stock in a research report on Friday, March 1st. Finally, Citigroup began coverage on shares of Privia Health Group in a research report on Monday. They set a “buy” rating and a $25.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Privia Health Group has an average rating of “Moderate Buy” and an average price target of $27.92.

Privia Health Group Stock Down 0.2 %

Privia Health Group stock opened at $18.05 on Tuesday. The company’s fifty day simple moving average is $20.02 and its 200-day simple moving average is $21.36. Privia Health Group, Inc. has a 12 month low of $17.54 and a 12 month high of $30.15. The stock has a market cap of $2.14 billion, a P/E ratio of 95.00, a P/E/G ratio of 2.47 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.02). Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. The company had revenue of $440.80 million for the quarter, compared to analysts’ expectations of $425.81 million. During the same quarter in the prior year, the firm earned $0.14 earnings per share. The company’s revenue was up 21.0% on a year-over-year basis. On average, equities research analysts expect that Privia Health Group, Inc. will post 0.26 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO David Mountcastle sold 3,933 shares of the company’s stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $17.77, for a total value of $69,889.41. Following the completion of the sale, the chief financial officer now directly owns 262,279 shares in the company, valued at $4,660,697.83. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director William M. Sullivan sold 9,951 shares of the company’s stock in a transaction on Wednesday, January 24th. The shares were sold at an average price of $23.03, for a total value of $229,171.53. Following the completion of the sale, the director now directly owns 5,464,533 shares in the company, valued at $125,848,194.99. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO David Mountcastle sold 3,933 shares of the company’s stock in a transaction on Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total transaction of $69,889.41. Following the completion of the sale, the chief financial officer now owns 262,279 shares of the company’s stock, valued at $4,660,697.83. The disclosure for this sale can be found here. 14.20% of the stock is currently owned by corporate insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.